Are there regional variations in the diagnosis surveillance, and control of methicillin-resistant Staphylococcus aureus?

Hervé M. Richet; Mohamed Benbachir; Derek F.J. Brown; Helen Giamarellou; Ian Gould; Marija Gubina; Piotr Heczko; Smilja Kalenic; Marina Pana; Didier Pittet; Saida Ben Redjeb; Jiri Schindler; Carlos Starling; Marc J. Struelens; Wolfgang Witte; William R. Jarvis; Horacio Lopardo; Manfred Rotter; Maja Ostjic; Jorge Saliba; Boyka Markova; Kwok Yung Yuen; Mireille Dosso; Ines Bencic; Nastja Kucisec-Tepes; Jasenta Skrlin; Edita Susic; Maja Tomic; D. Burgetova; Andre-Richet; D. Barraud; Besnard; Edouard Bichier; M. Bingen; Catherine Branger; Anne Cirioni; Stephanie Clavel; Simone Clévenot; Andréa Collet; François Coulomb; Patrice Courvalin; Armelle David; François Denis; Marie Cécile Ploy; Jean Yves Esvant; Ferrant; Annick Genuis; Guir; Didier Jan; Françoise Jezequel; Jean Louis Laborie; Florence Le Gallou; Lemoign; Christine Rennes; Pascale Richard; Yveline Ruellan; Jacques Vaucel; Liliane Zbierski; Barbel Christiansen; Julia Fitzner; Mathias Hermann; Michael Kramer; Werner Mathys; Sabine Schubert; Stefan Weber; A. Katrachoura; E. A. Papafrangas; Danae Sofianou; Anna Marton; Nathan Keller; Ethan Rubinstein; Giuseppe Cornaglia; Jurjis Perevostikos; Ivonna Selga; Robert Hemmer; M. A. Alaoui; A. Benouda-Benjilaji; J. H.T. Wagenvoort; M. Pytlos; Waleria Hryniewicz; Manuela Anda Andrei; Dana Andries; Daniela Blana; Lucia Debeleac; Olga Dorobat; Antonia Medvetchi-Panatescu; Irina Nistor; Raluca Papagheorge; Elena Silaghi; Daniela Tudorache; Andrei Dekhitch; Leonid Stratchounski; S. B.Cheikh Boye; Katja Seme; Javier Garau; Ferran Navarro; Guillem Prats; Antoni Trilla

doi:10.1086/502216

Are there regional variations in the diagnosis surveillance, and control of methicillin-resistant Staphylococcus aureus?

Hervé M. Richet, Mohamed Benbachir, Derek F.J. Brown, Helen Giamarellou, Ian Gould, Marija Gubina, Piotr Heczko, Smilja Kalenic, Marina Pana, Didier Pittet, Saida Ben Redjeb, Jiri Schindler, Carlos Starling, Marc J. Struelens, Wolfgang Witte, William R. Jarvis, Horacio Lopardo, Manfred Rotter, Maja Ostjic, Jorge SalibaBoyka Markova, Kwok Yung Yuen, Mireille Dosso, Ines Bencic, Nastja Kucisec-Tepes, Jasenta Skrlin, Edita Susic, Maja Tomic, D. Burgetova, Andre-Richet, D. Barraud, Besnard, Edouard Bichier, M. Bingen, Catherine Branger, Anne Cirioni, Stephanie Clavel, Simone Clévenot, Andréa Collet, François Coulomb, Patrice Courvalin, Armelle David, François Denis, Marie Cécile Ploy, Jean Yves Esvant, Ferrant, Annick Genuis, Guir, Didier Jan, Françoise Jezequel, Jean Louis Laborie, Florence Le Gallou, Lemoign, Christine Rennes, Pascale Richard, Yveline Ruellan, Jacques Vaucel, Liliane Zbierski, Barbel Christiansen, Julia Fitzner, Mathias Hermann, Michael Kramer, Werner Mathys, Sabine Schubert, Stefan Weber, A. Katrachoura, E. A. Papafrangas, Danae Sofianou, Anna Marton, Nathan Keller, Ethan Rubinstein, Giuseppe Cornaglia, Jurjis Perevostikos, Ivonna Selga, Robert Hemmer, M. A. Alaoui, A. Benouda-Benjilaji, J. H.T. Wagenvoort, M. Pytlos, Waleria Hryniewicz, Manuela Anda Andrei, Dana Andries, Daniela Blana, Lucia Debeleac, Olga Dorobat, Antonia Medvetchi-Panatescu, Irina Nistor, Raluca Papagheorge, Elena Silaghi, Daniela Tudorache, Andrei Dekhitch, Leonid Stratchounski, S. B.Cheikh Boye, Katja Seme, Javier Garau, Ferran Navarro, Guillem Prats, Antoni Trilla

Department of Health Systems Management

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

OBJECTIVE: To assess the way healthcare facilities (HCFs) diagnose, survey, and control methicillin-resistant Staphylococcus aureus (MRSA). DESIGN: Questionnaire. SETTING: Ninety HCFs in 30 countries. RESULTS: Evaluation of susceptibility testing methods showed that 8 laboratories (9%) used oxacillin disks with antimicrobial content different from the one recommended, 12 (13%) did not determine MRSA susceptibility to vancomycin, and 4 (4.5%) reported instances of isolation of vancomycin-resistant S. aureus but neither confirmed this resistance nor alerted public health authorities. A MRSA control program was reported by 55 (61.1%) of the HCFs. The following isolation precautions were routinely used: hospitalization in a private room (34.4%), wearing of gloves (62.2%), wearing of gowns (44.4%), hand washing by healthcare workers (53.3%), use of an isolation sign on the patient's door (43%), or all four. When the characteristics of HCFs with low incidence rates (< 0.4 per 1,000 patient-days) were compared with those of HCFs with high incidence rates (≥ 0.4 per 1,000 patient-days), having a higher mean number of beds per infection control nurse was the only factor significantly associated with HCFs with high incidence rates (834 vs 318 beds; P = .02). CONCLUSION: Our results emphasize the urgent need to strengthen the microbiologic and epidemiologic capacities of HCFs worldwide to prevent MRSA transmission and to prepare them to address the possible emergence of vancomycin-resistant S. aureus.

Original language	English
Pages (from-to)	334-341
Number of pages	8
Journal	Infection Control and Hospital Epidemiology
Volume	24
Issue number	5
DOIs	https://doi.org/10.1086/502216
State	Published - 1 May 2003

Access to Document

10.1086/502216

Cite this

Richet, H. M., Benbachir, M., Brown, D. F. J., Giamarellou, H., Gould, I., Gubina, M., Heczko, P., Kalenic, S., Pana, M., Pittet, D., Redjeb, S. B., Schindler, J., Starling, C., Struelens, M. J., Witte, W., Jarvis, W. R., Lopardo, H., Rotter, M., Ostjic, M., ... Trilla, A. (2003). Are there regional variations in the diagnosis surveillance, and control of methicillin-resistant Staphylococcus aureus? Infection Control and Hospital Epidemiology, 24(5), 334-341. https://doi.org/10.1086/502216

@article{fb559d5dd668425d9db821adddf7aef2,

title = "Are there regional variations in the diagnosis surveillance, and control of methicillin-resistant Staphylococcus aureus?",

abstract = "OBJECTIVE: To assess the way healthcare facilities (HCFs) diagnose, survey, and control methicillin-resistant Staphylococcus aureus (MRSA). DESIGN: Questionnaire. SETTING: Ninety HCFs in 30 countries. RESULTS: Evaluation of susceptibility testing methods showed that 8 laboratories (9%) used oxacillin disks with antimicrobial content different from the one recommended, 12 (13%) did not determine MRSA susceptibility to vancomycin, and 4 (4.5%) reported instances of isolation of vancomycin-resistant S. aureus but neither confirmed this resistance nor alerted public health authorities. A MRSA control program was reported by 55 (61.1%) of the HCFs. The following isolation precautions were routinely used: hospitalization in a private room (34.4%), wearing of gloves (62.2%), wearing of gowns (44.4%), hand washing by healthcare workers (53.3%), use of an isolation sign on the patient's door (43%), or all four. When the characteristics of HCFs with low incidence rates (< 0.4 per 1,000 patient-days) were compared with those of HCFs with high incidence rates (≥ 0.4 per 1,000 patient-days), having a higher mean number of beds per infection control nurse was the only factor significantly associated with HCFs with high incidence rates (834 vs 318 beds; P = .02). CONCLUSION: Our results emphasize the urgent need to strengthen the microbiologic and epidemiologic capacities of HCFs worldwide to prevent MRSA transmission and to prepare them to address the possible emergence of vancomycin-resistant S. aureus.",

author = "Richet, {Herv{\'e} M.} and Mohamed Benbachir and Brown, {Derek F.J.} and Helen Giamarellou and Ian Gould and Marija Gubina and Piotr Heczko and Smilja Kalenic and Marina Pana and Didier Pittet and Redjeb, {Saida Ben} and Jiri Schindler and Carlos Starling and Struelens, {Marc J.} and Wolfgang Witte and Jarvis, {William R.} and Horacio Lopardo and Manfred Rotter and Maja Ostjic and Jorge Saliba and Boyka Markova and Yuen, {Kwok Yung} and Mireille Dosso and Ines Bencic and Nastja Kucisec-Tepes and Jasenta Skrlin and Edita Susic and Maja Tomic and D. Burgetova and Andre-Richet and D. Barraud and Besnard and Edouard Bichier and M. Bingen and Catherine Branger and Anne Cirioni and Stephanie Clavel and Simone Cl{\'e}venot and Andr{\'e}a Collet and Fran{\c c}ois Coulomb and Patrice Courvalin and Armelle David and Fran{\c c}ois Denis and Ploy, {Marie C{\'e}cile} and Esvant, {Jean Yves} and Ferrant and Annick Genuis and Guir and Didier Jan and Fran{\c c}oise Jezequel and Laborie, {Jean Louis} and {Le Gallou}, Florence and Lemoign and Christine Rennes and Pascale Richard and Yveline Ruellan and Jacques Vaucel and Liliane Zbierski and Barbel Christiansen and Julia Fitzner and Mathias Hermann and Michael Kramer and Werner Mathys and Sabine Schubert and Stefan Weber and A. Katrachoura and Papafrangas, {E. A.} and Danae Sofianou and Anna Marton and Nathan Keller and Ethan Rubinstein and Giuseppe Cornaglia and Jurjis Perevostikos and Ivonna Selga and Robert Hemmer and Alaoui, {M. A.} and A. Benouda-Benjilaji and Wagenvoort, {J. H.T.} and M. Pytlos and Waleria Hryniewicz and Andrei, {Manuela Anda} and Dana Andries and Daniela Blana and Lucia Debeleac and Olga Dorobat and Antonia Medvetchi-Panatescu and Irina Nistor and Raluca Papagheorge and Elena Silaghi and Daniela Tudorache and Andrei Dekhitch and Leonid Stratchounski and Boye, {S. B.Cheikh} and Katja Seme and Javier Garau and Ferran Navarro and Guillem Prats and Antoni Trilla",

year = "2003",

month = may,

day = "1",

doi = "10.1086/502216",

language = "אנגלית",

volume = "24",

pages = "334--341",

journal = "Infection Control and Hospital Epidemiology",

issn = "0899-823X",

publisher = "Cambridge University Press",

number = "5",

}

Richet, HM, Benbachir, M, Brown, DFJ, Giamarellou, H, Gould, I, Gubina, M, Heczko, P, Kalenic, S, Pana, M, Pittet, D, Redjeb, SB, Schindler, J, Starling, C, Struelens, MJ, Witte, W, Jarvis, WR, Lopardo, H, Rotter, M, Ostjic, M, Saliba, J, Markova, B, Yuen, KY, Dosso, M, Bencic, I, Kucisec-Tepes, N, Skrlin, J, Susic, E, Tomic, M, Burgetova, D, Andre-Richet, Barraud, D, Besnard, Bichier, E, Bingen, M, Branger, C, Cirioni, A, Clavel, S, Clévenot, S, Collet, A, Coulomb, F, Courvalin, P, David, A, Denis, F, Ploy, MC, Esvant, JY, Ferrant, Genuis, A, Guir, Jan, D, Jezequel, F, Laborie, JL, Le Gallou, F, Lemoign, Rennes, C, Richard, P, Ruellan, Y, Vaucel, J, Zbierski, L, Christiansen, B, Fitzner, J, Hermann, M, Kramer, M, Mathys, W, Schubert, S, Weber, S, Katrachoura, A, Papafrangas, EA, Sofianou, D, Marton, A, Keller, N, Rubinstein, E, Cornaglia, G, Perevostikos, J, Selga, I, Hemmer, R, Alaoui, MA, Benouda-Benjilaji, A, Wagenvoort, JHT, Pytlos, M, Hryniewicz, W, Andrei, MA, Andries, D, Blana, D, Debeleac, L, Dorobat, O, Medvetchi-Panatescu, A, Nistor, I, Papagheorge, R, Silaghi, E, Tudorache, D, Dekhitch, A, Stratchounski, L, Boye, SBC, Seme, K, Garau, J, Navarro, F, Prats, G & Trilla, A 2003, 'Are there regional variations in the diagnosis surveillance, and control of methicillin-resistant Staphylococcus aureus?', Infection Control and Hospital Epidemiology, vol. 24, no. 5, pp. 334-341. https://doi.org/10.1086/502216